<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7906073</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4424</journal-id>
<journal-id journal-id-type="nlm-ta">J Affect Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Affect Disord</journal-id>
<journal-title-group>
<journal-title>Journal of affective disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">0165-0327</issn>
<issn pub-type="epub">1573-2517</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30071418</article-id>
<article-id pub-id-type="pmc">6108934</article-id>
<article-id pub-id-type="doi">10.1016/j.jad.2018.07.075</article-id>
<article-id pub-id-type="manuscript">NIHMS1502229</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MicroRNAs in Depression and Suicide: Recent Insights and Future Perspectives</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dwivedi</surname>
<given-names>Yogesh</given-names>
</name>
<degrees>Ph.D.</degrees>
</contrib>
<aff id="A1">Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama-35294, USA</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><bold>Address for Correspondence</bold> Yogesh Dwivedi, Ph.D., Elesabeth Ridgely Shook Endowed Chair in Psychiatry, Professor of Psychiatry, Director of Translational Research, UAB Mood Disorder Program, Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, SC711 Sparks Center, 1720 7<sup>th</sup> Avenue South, Birmingham, Alabama, USA, Phone: 01-205-975-8459, Fax: 01-205-975-8463, <email>ydwivedi@uab.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>31</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>240</volume>
<fpage>146</fpage>
<lpage>154</lpage>
<!--elocation-id from pubmed: 10.1016/j.jad.2018.07.075-->
<abstract id="ABS1">
<p id="P1">Suicide is a major public health concern. A significant proportion of depressed individuals show suicidal ideation. The currently available medications are not optimal and a large number of depressed/suicidal patients do not respond to these medications. Thus, there is an urgent need to fully understand the neurobiological mechanisms associated with depression and suicidal behavior and to find novel targets for therapeutic interventions. In this regard, microRNAs (miRNAs), member of small non-coding RNA family, have emerged as an invaluable tool not only to understand disease pathogenesis but also to precisely pinpoint the targets that can be developed as drugs. In this review, these aspects have been discussed in a comprehensive and critical manner.</p>
</abstract>
<kwd-group>
<kwd>miRNAs</kwd>
<kwd>depression</kwd>
<kwd>suicide</kwd>
<kwd>stress</kwd>
<kwd>neural plasticity</kwd>
<kwd>biomarker</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>